Recruiting
Phase 3

Glepaglutide

Sponsor:

Zealand Pharma

Code:

NCT07197944

Conditions

Short Bowel Syndrome

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Glepaglutide

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-25. This information was provided to ClinicalTrials.gov by Zealand Pharma on 2026-08-12.